Epigral Ltd vs Galaxy Surfactants Ltd Stock Comparison

Home

Insights

Stock Comparison

Last Updated on: Mar 18, 2026

Key Highlights

The Latest Trading Price of Epigral Ltd is ₹ 856.45 as of 18 Mar 15:30 . The P/E Ratio of Epigral Ltd changed from 16 on March 2022 to 22.9 on March 2025 . This represents a CAGR of 9.38% over 4 yearsThe P/E Ratio of Galaxy Surfactants Ltd changed from 30 on March 2021 to 23.9 on March 2025 . This represents a CAGR of -4.44% over 5 years The Market Cap of Epigral Ltd changed from ₹ 4045 crore on March 2022 to ₹ 8191 crore on March 2025 . This represents a CAGR of 19.29% over 4 yearsThe Market Cap of Galaxy Surfactants Ltd changed from ₹ 9059 crore on March 2021 to ₹ 7272 crore on March 2025 . This represents a CAGR of -4.30% over 5 years The revenue of Epigral Ltd for the Dec '25 is ₹ 602.68 crore as compare to the Sep '25 revenue of ₹ 589.1 crore. This represent the growth of 2.31% The revenue of Galaxy Surfactants Ltd for the Dec '25 is ₹ 1334 crore as compare to the Sep '25 revenue of ₹ 1331 crore. This represent the growth of 0.17% The ebitda of Epigral Ltd for the Dec '25 is ₹ 108.26 crore as compare to the Sep '25 ebitda of ₹ 133.8 crore. This represent the decline of -19.09% The ebitda of Galaxy Surfactants Ltd for the Dec '25 is ₹ 112.27 crore as compare to the Sep '25 ebitda of ₹ 116.29 crore. This represent the decline of -3.46% The net profit of Epigral Ltd changed from ₹ 85.87 crore to ₹ 39.11 crore over 7 quarters. This represents a CAGR of -36.20% The net profit of Galaxy Surfactants Ltd changed from ₹ 79.72 crore to ₹ 58.97 crore over 7 quarters. This represents a CAGR of -15.83% The Dividend Payout of Epigral Ltd changed from 5.88 % on March 2023 to 7.26 % on March 2025 . This represents a CAGR of 7.28% over 3 yearsThe Dividend Payout of Galaxy Surfactants Ltd changed from 35.88 % on March 2021 to 8.16 % on March 2025 . This represents a CAGR of -25.64% over 5 years .

About Epigral Ltd

Epigral Limited was erstwhile incorporated as 'Meghmani Finechem Limited' in 2007, which is engaged in manufacturing and selling of Chlor Alkali & its Derivatives and also in Trading of Agrochemical products.
The Company was incorporated as a subsidiary of Meghmani Organics Limited. Meghmani Finechem Limited (MFL) was demerged from Meghmani Organics Limited (MOL) as a going concern, through the Scheme of Arrangement for Demerger and the said Scheme became effective from May 10, 2021.
The Chlor-Alkali business commissioned in 2009, growing from an installed capacity of 1,88,000 TPA in 2015 to 3,15,000 TPA at the close of FY 2020-21.
The Company is now among the leading players in India's chlor alkali industry.
In terms of the said Scheme, the Company allotted 2,39,03,029 Equity Shares of Rs 10/- each on 20th May, 2021 to the shareholders of Meghmani Organics Limited.

About Galaxy Surfactants Ltd

Galaxy Surfactants Limited was originally incorporated as a private limited Company with the name 'Galaxy Surfactants Private Limited' on May 20, 1986.
Subsequently, the Company was converted into a Public Limited company and the name of the Company was changed to 'Galaxy Surfactants Limited' on March 13, 1995. Since the establishment in 1980, Company achieved significant growth, by extending the count to over 80 countries.
Its diverse portfolio make more than 215 products, and serve a customer base exceeding 1,500 clients.
These manufacturing facilities, strategically located in India, Egypt, and the USA, ensure a robust and reliable supply chain, with the commitment to quality and innovation. Galaxy Surfactants is one of India's leading manufacturers of Surfactants and other Specialty Care Ingredients catering to the Home and Personal Care Industry.

FAQs for the comparison of Epigral Ltd and Galaxy Surfactants Ltd

Which company has a larger market capitalization, Epigral Ltd or Galaxy Surfactants Ltd?

Market cap of Epigral Ltd is 3,694 Cr while Market cap of Galaxy Surfactants Ltd is 6,144 Cr

What are the key factors driving the stock performance of Epigral Ltd and Galaxy Surfactants Ltd?

The stock performance of Epigral Ltd and Galaxy Surfactants Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Epigral Ltd and Galaxy Surfactants Ltd?

As of March 18, 2026, the Epigral Ltd stock price is INR ₹856.45. On the other hand, Galaxy Surfactants Ltd stock price is INR ₹1733.15.

How do dividend payouts of Epigral Ltd and Galaxy Surfactants Ltd compare?

To compare the dividend payouts of Epigral Ltd and Galaxy Surfactants Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.

Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.